e-learning
resources
Amsterdam 2015
Wednesday, 30.09.2015
Inhaled drugs: within and beyond the lungs
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New inhaler devices: the good, the bad, and the ugly
Federico Lavorini (Florence, Italy)
Source:
International Congress 2015 – Inhaled drugs: within and beyond the lungs
Session:
Inhaled drugs: within and beyond the lungs
Session type:
Symposium
Number:
4941
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Federico Lavorini (Florence, Italy). New inhaler devices: the good, the bad, and the ugly. International Congress 2015 – Inhaled drugs: within and beyond the lungs
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Mobile video directly observed therapy can be used to improve at-home inhaler technique in children with asthma
Clinically appropriate testing of different valved holding chamber (VHC)-facemask combinations investigating simulated delivered mass to carina
Asthma control using a combination of mometasone furoate/formoterol: Grouped analysis of three clinical trials
Related content which might interest you:
New (or old?) drugs for bad bugs
Source: International Congress 2015 – Antibiotic resistance in respiratory infections
Year: 2015
How does the Novolizer fit into the choice of inhaler?
Source: Annual Congress 2005 - Asthma management - important issues
Year: 2005
Antibiotics in acute exacerbations of COPD: the good, the bad and the ugly
Source: Eur Respir J 2012; 40: 1-3
Year: 2012
Getting it right: What does inhaler choice mean for patient outcomes?
Source: International Congress 2019 – Putting COPD patient needs first: Time for optimizing treatment and device selection
Year: 2019
How to choose and use an inhaler device?
Source: Virtual Congress 2021 – Updates on inhalers for COPD and asthma
Year: 2021
Foundation doctor knowledge of inhaled devices - Are the old better than the new?
Source: International Congress 2016 – Abstracts in medical education, the web and the internet
Year: 2016
Late Breaking Abstract - Switching from a disposable to a re-usable inhaler: patient satisfaction and preference
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Electronic monitoring devices: the saviour of poor control in asthma?
Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Year: 2018
How to select an inhaler?
Source: Virtual Congress 2020 – Inhalers for COPD and asthma: reviews
Year: 2020
Indoor microbial exposure and asthma : about good and bad guys and what do we know so far
Source: International Congress 2017 – Chemical and biological indoor and outdoor pollution
Year: 2017
Handout How to deliver bad news
Source: Amsterdam 2015 - Educational material
Year: 2015
The curious incident of the inhaler using dog and other remarkable inhaler technique stories from real-life clinical practice. An IRW study
Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence
Year: 2017
How can we improve patient use of inhaler devices in COPD?
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011
A thousand years of pulmonary medicine: good news and bad
Source: Eur Respir J 2001; 17: 558-565
Year: 2001
Shorter treatment for multidrug-resistant tuberculosis: the good, the bad and the ugly
Source: Eur Respir J 2016; 48: 1800-1802
Year: 2016
Bronchiectasis: the new, the old and the ugly
Source: International Congress 2018 – State of the art session: Respiratory infections
Year: 2018
Don’t procrastinate, ventilate! - a quality improvement project.
Source: International Congress 2019 – Treatment of acute respiratory failure with noninvasive ventilation
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept